Achieve Life Sciences, Inc.

US$6.72As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ACHVHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (39.71%)
Div yield —
ROE (844.99%)
Biotechnology
Beta (5Y) 2.41
PE TTM —
TSR TTM 31.25%
Mkt cap US$691.5M
ROIC (140.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.50
26.56%
3.36%
Hold 2|11|3|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.09
0.09
0.09
20.43%
15.81%
18.21%
15.31%
Revenue$M
89.94
90.86
89.49
88.24
9.71%
11.72%
4.81%
0.95%
Peers (US$691.5M)
Cap (US$)
PE
689.7M
9.429x
681.7M
26.80x
Capital
TTM
5Y
10Y
Leveragex
0.562
0.869
0.780
EBIT/Intx
1.503
0.275
0.265
Own earn%
(46.77)
62.54
92.16
Sh yield%
21.95
22.73
23.67
Owners
Insiders/Inst%
8.03
34.43
Short interest%
1.91
SBC / revenue%
4.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
24–29
$1 testx
—
Incr. ROIC%
6